PatternsRadar
Sign in

SGRLSGRL

NSE
Full chart
719.05INR+38.65 (+5.68%)Close · 6 Oct 2026
—Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹923 CrMarket cap
—P/E (TTM)
50.0%Delivery

Growth

CSV
Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open690.00
Day range690.00 – 734.25
52-week range—
From 52w high—
RSI (14)62.0
ATR (14)45.04
Volume31.5K
Avg volume (20D)22.5K
Rel volume1.40×
Volatility (1Y)66.0%
Turnover₹2.3Cr
SMA 50 / 200— / —

Delivery percentage

Latest · 6 Oct 202650.0%
20-day avg59.7%
1-year avg63.6%
Percentile (own history)6th
Range46.2–80.9%
Sessions35

Over the last 20 sessions SGRL settled 59.7% of its traded quantity, which is above average for an NSE equity.

What delivery percentage measuresScan the whole market on delivery

Performance returns

CSV
1D1W1M3M6M1Y
Price+5.68%+5.73%+5.11%———

Valuation

CSV
Market cap₹923 Cr
P/E (TTM)—
EPS (TTM)—
Shares outstanding—
Listed17 Aug 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

SGRL at a glance

  • SGRL closed at ₹719.05 on 6 Oct 2026, +5.68% on the day.
  • Delivery was 50.0% of traded quantity on 6 Oct 2026, the 6th percentile of its own 35 sessions with a reading (20-session average 59.7%, 1-year average 63.6%).
  • Market capitalisation is ₹923 crore, with no positive trailing earnings for a P/E.